179 related articles for article (PubMed ID: 23890163)
21. Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies.
Pedrazzoli P; Da Prada GA; Giorgiani G; Schiavo R; Zambelli A; Giraldi E; Landonio G; Locatelli F; Siena S; Della Cuna GR
Cancer; 2002 May; 94(9):2409-15. PubMed ID: 12015766
[TBL] [Abstract][Full Text] [Related]
22. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation.
Rizzo JD; Wingard JR; Tichelli A; Lee SJ; Van Lint MT; Burns LJ; Davies SM; Ferrara JL; Socié G
Biol Blood Marrow Transplant; 2006 Feb; 12(2):138-51. PubMed ID: 16443512
[TBL] [Abstract][Full Text] [Related]
23. Reimmunization after blood or marrow stem cell transplantation.
Singhal S; Mehta J
Bone Marrow Transplant; 1999 Apr; 23(7):637-46. PubMed ID: 10218839
[TBL] [Abstract][Full Text] [Related]
24. Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literature.
Daikeler T; Kötter I; Bocelli Tyndall C; Apperley J; Attarbaschi A; Guardiola P; Gratwohl A; Jantunen E; Marmont A; Porretto F; Musso M; Maurer B; Rinaldi N; Saccardi R; Tyndall A;
Ann Rheum Dis; 2007 Feb; 66(2):202-7. PubMed ID: 16950809
[TBL] [Abstract][Full Text] [Related]
25. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
26. Sociodemographic and psychological determinants of influenza vaccine intention among recipients of autologous and allogeneic haematopoietic stem cell transplant: a cross-sectional survey of UK transplant recipients using a modified health belief model.
Miller PDE; Forster AS; de Silva TI; Leonard H; Anthias C; Mayhew M; Klammer M; Paskar S; Hurst E; Peggs K; Madrigal A; Snowden JA
BMJ Open; 2018 Aug; 8(8):e021222. PubMed ID: 30093515
[TBL] [Abstract][Full Text] [Related]
27. Iron overload: predictor of adverse outcome in hematopoietic stem cell transplantation.
Sucak GT; Yegin ZA; Ozkurt ZN; Aki SZ; Yağci M
Transplant Proc; 2010 Jun; 42(5):1841-8. PubMed ID: 20620535
[TBL] [Abstract][Full Text] [Related]
28. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
Bierman PJ; Sweetenham JW; Loberiza FR; Taghipour G; Lazarus HM; Rizzo JD; Schmitz N; van Besien K; Vose JM; Horowitz M; Goldstone A;
J Clin Oncol; 2003 Oct; 21(20):3744-53. PubMed ID: 12963703
[TBL] [Abstract][Full Text] [Related]
29. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients.
; ;
MMWR Recomm Rep; 2000 Oct; 49(RR-10):1-125, CE1-7. PubMed ID: 11718124
[TBL] [Abstract][Full Text] [Related]
30. Vaccination guidelines after hematopoietic stem cell transplantation: practitioners' knowledge, attitudes, and gap between guidelines and clinical practice.
Ariza-Heredia EJ; Gulbis AM; Stolar KR; Kebriaei P; Shah DP; McConn KK; Champlin RE; Chemaly RF
Transpl Infect Dis; 2014 Dec; 16(6):878-86. PubMed ID: 25405922
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of timing of first vaccination in children after hematopoietic allogeneic stem cell transplantation.
Bauters T; Bordon Cueto De Braem V; Schelstraete P; Van Lancker S; Laureys G; Benoit Y; Dhooge C
Eur J Oncol Nurs; 2016 Apr; 21():212-4. PubMed ID: 26645948
[TBL] [Abstract][Full Text] [Related]
32. A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients.
Kumar D; Chen MH; Welsh B; Siegal D; Cobos I; Messner HA; Lipton J; Humar A
Clin Infect Dis; 2007 Dec; 45(12):1576-82. PubMed ID: 18190318
[TBL] [Abstract][Full Text] [Related]
33. Review and revision of clinical practice of using G-CSF after autologous and allogeneic hematopoietic stem cell transplantation at UCSD.
Trivedi M; Martinez S; Corringham S; Medley K; Ball ED
J Oncol Pharm Pract; 2011 Jun; 17(2):85-90. PubMed ID: 20015929
[TBL] [Abstract][Full Text] [Related]
34. VaccHemInf project: protocol for a prospective cohort study of efficacy, safety and characterisation of immune functional response to vaccinations in haematopoietic stem cell transplant recipients.
Conrad A; Boccard M; Valour F; Alcazer V; Tovar Sanchez AT; Chidiac C; Laurent F; Vanhems P; Salles G; Brengel-Pesce K; Meunier B; Trouillet-Assant S; Ader F;
BMJ Open; 2019 Feb; 9(2):e026093. PubMed ID: 30772864
[TBL] [Abstract][Full Text] [Related]
35. Early infectious complications in autologous bone marrow transplantation: a review of 219 patients.
Mossad SB; Longworth DL; Goormastic M; Serkey JM; Keys TF; Bolwell BJ
Bone Marrow Transplant; 1996 Aug; 18(2):265-71. PubMed ID: 8864433
[TBL] [Abstract][Full Text] [Related]
36. Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.
Gueller S; Duenzinger U; Wolf T; Ajib S; Mousset S; Berger A; Martin H; Serve H; Bug G
Transpl Infect Dis; 2013 Aug; 15(4):435-40. PubMed ID: 23692664
[TBL] [Abstract][Full Text] [Related]
37. Allogeneic bone marrow vs. peripheral blood stem cell transplantation: a long-term retrospective single-center analysis in 329 patients.
Auberger J; Clausen J; Kircher B; Kropshofer G; Lindner B; Nachbaur D
Eur J Haematol; 2011 Dec; 87(6):531-8. PubMed ID: 21848700
[TBL] [Abstract][Full Text] [Related]
38. The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic.
Engelhard D; Zakay-Rones Z; Shapira MY; Resnick I; Averbuch D; Grisariu S; Dray L; Djian E; Strauss-Liviatan N; Grotto I; Wolf DG; Or R
Vaccine; 2011 Feb; 29(9):1777-82. PubMed ID: 21216315
[TBL] [Abstract][Full Text] [Related]
39. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation.
Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT
Clin Infect Dis; 2007 Mar; 44(5):625-34. PubMed ID: 17278051
[TBL] [Abstract][Full Text] [Related]
40. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
